Atlas Trials

Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

RecordFirmDate
Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients (NCT01444417)Amgen2012-01-01
Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects (NCT00515203)Amgen2007-07-01
Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura (NCT00415532)Amgen2006-12-01
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) (NCT00454857)Amgen2006-05-01
Safety Study of AMG 531 in Japanese Subjects With ITP (NCT00305435)Kyowa Kirin Co., Ltd.2006-02-01

Track Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) automatically

Every clearance here is in the API, with alerts when new ones post.